Clinical Trials
2 trialsNCT01918761 2019-12-30
Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
Central European Cooperative Oncology Group
Phase 1 Terminated
NCT02047747 2016-09-22
A Phase II Study of Dacomitinib in Progressive Brain Metastases
University of California, San Diego
Phase 2 Terminated